US Physical Therapy Inc (N:USPH)
Business Focus: Hospitals, Clinics & Primary Care Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 1300 West Sam Houston Parkway, Suite 300 HOUSTON TX 77043 |
| Tel: | N/A |
| Website: | https://www.usph.com |
| IR: | See website |
| Key People | ||
| Christopher J. Reading President, Chief Executive Officer, Director | Carey P. Hendrickson Chief Financial Officer | Richard S Binstein Executive Vice President, General Counsel, Secretary |
| Graham D. Reeve Chief Operating Officer - West | Eric J. Williams Chief Operating Officer - East | |
| Business Overview |
| U.S. Physical Therapy, Inc. is engaged in physical therapy operations and provides industrial injury prevention services. The Company is engaged in physical therapy operations primarily through its subsidiary, clinic partnerships. The Company's physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. It operates approximately 678 outpatient physical therapy clinics in 42 states. The Company's industrial injury prevention services include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. It performs these services through Industrial Sports Medicine Professionals, consisting primarily of specialized certified athletic trainers (ATCs). |
| Financial Overview |
| For the fiscal year ended 31 December 2023, US Physical Therapy Inc revenues increased 9% to $604.8M. Net income applicable to common stockholders decreased 38% to $18.1M. Revenues reflect Physical therapy operations segment increase of 13% to $526.5M, Industrial injury prevention services segment increase of 2% to $78.3M. Net income was offset by Impairment of goodwill and other intangi increase of 92% to $17.5M (expense). |
| Employees: | 3,899 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $1,556M as of Dec 31, 2023 |
| Annual revenue (TTM): | $604.80M as of Dec 31, 2023 |
| EBITDA (TTM): | $85.25M as of Dec 31, 2023 |
| Net annual income (TTM): | $18.14M as of Dec 31, 2023 |
| Free cash flow (TTM): | $59.79M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 15,068,085 as of Mar 25, 2024 |
| Index Membership: | S&P 600 Small Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.